派博傳思國(guó)際中心

標(biāo)題: Titlebook: Management of Chemotherapy-Induced Nausea and Vomiting; New Agents and New U Rudolph M. Navari Book 2016 Springer International Publishing [打印本頁(yè)]

作者: FLAK    時(shí)間: 2025-3-21 17:59
書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting影響因子(影響力)




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting被引頻次




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting被引頻次學(xué)科排名




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting年度引用




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting年度引用學(xué)科排名




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting讀者反饋




書(shū)目名稱(chēng)Management of Chemotherapy-Induced Nausea and Vomiting讀者反饋學(xué)科排名





作者: 祖先    時(shí)間: 2025-3-21 20:50
http://image.papertrans.cn/m/image/622459.jpg
作者: companion    時(shí)間: 2025-3-22 01:49
Clinical Management of CINV,Antiemetic guidelines have been published by NCCN [1], ASCO [2], and MASCC [3]. These guidelines form the basis for the recommendations for the management of CINV. As new information and new studies emerge, the guidelines will evolve to provide the highest quality evidence-based clinical practice.
作者: Pudendal-Nerve    時(shí)間: 2025-3-22 07:29

作者: 建筑師    時(shí)間: 2025-3-22 12:13

作者: eczema    時(shí)間: 2025-3-22 13:02
Conclusions,milar efficacy in the prevention of acute CINV for patients receiving moderately emetogenic chemotherapy (MEC) and highly emetogenic chemotherapy (HEC). These agents do not appear to have significant efficacy in the prevention of delayed CINV, and these agents compete primarily on an economic basis.
作者: Opponent    時(shí)間: 2025-3-22 17:46

作者: filial    時(shí)間: 2025-3-22 22:31

作者: adduction    時(shí)間: 2025-3-23 03:02

作者: modifier    時(shí)間: 2025-3-23 08:53

作者: 赦免    時(shí)間: 2025-3-23 13:34

作者: DAFT    時(shí)間: 2025-3-23 17:22

作者: 大包裹    時(shí)間: 2025-3-23 20:29

作者: Hla461    時(shí)間: 2025-3-23 23:39

作者: –DOX    時(shí)間: 2025-3-24 04:10
Rudolph M. Navari MD, PhD, FACP to large shareholder groups of family businesses.Follows a .This book deals with dynastic business families. Such families are characterized by a circle of owners comprising more than 50 family members, which typically face specific issues and challenges for which there has been little research kno
作者: Console    時(shí)間: 2025-3-24 07:54
Rudolph M. Navari MD, PhD, FACPves exclusive insight into his way of detecting and investig.This book deals with the highly complex but exciting subject of corporate fraud and corruption, which has since become the cops and robbers game of the 21st century: accounting fraud, embezzlement, bribery and many other forms of corruptio
作者: Tidious    時(shí)間: 2025-3-24 12:25
Rudolph M. Navari MD, PhD, FACPous methods to coordinate independent channel members, a number of studies in the literature suggest quantity discount as a mechanism to achieve incentive-compatible coordination between a seller/manufacturer and his buyer/retailer. The rationale behind this coordination mechanism is that a quantity
作者: extract    時(shí)間: 2025-3-24 17:25

作者: chondromalacia    時(shí)間: 2025-3-24 21:13
The Physiology and Pharmacology of Nausea and Vomiting Induced by Anticancer Chemotherapy in Humanselatively little was known about how cancer chemotherapeutic agents induced emesis until research was prompted by the clinical use of cisplatin thirty years later. The acute phase of cisplatin-induced emesis is predominantly driven by 5-hydroxytryptamine released from enterochromaffin cells in the s
作者: PON    時(shí)間: 2025-3-24 23:38

作者: interlude    時(shí)間: 2025-3-25 07:04

作者: essential-fats    時(shí)間: 2025-3-25 08:16

作者: 珊瑚    時(shí)間: 2025-3-25 15:19

作者: 乳汁    時(shí)間: 2025-3-25 19:16
Gabapentin for the Prevention of CINV,ures. Gabapentin was soon found to be highly effective for treating neuropathic pain [1] and then restless legs syndrome [2] and presently is FDA approved for all three indications. Despite its chemical structure, gabapentin has no effect on GABA receptors or GABA breakdown by GABA transaminase but
作者: BLANK    時(shí)間: 2025-3-26 00:03
Prevention of CINV in Patients Receiving High-Dose Multiple-Day Chemotherapy,e range of high-dose regimens has been developed and they typically consist of several agents given at high doses over 2–7 days. The use of peripheral blood as a source of stem cells for autologous hematopoietic stem-cell transplantation (HSCT) greatly contributed to the application of myeloablative
作者: 諂媚于性    時(shí)間: 2025-3-26 03:16
Treatment of Chemotherapy-Induced Nausea,jor adverse effect of the treatment [1]. The use of 5-hydroxytryptamine-3 (5-HT.) receptor antagonists plus dexamethasone has significantly improved the control of CINV [2]. Recent studies have demonstrated additional improvement in the control of CINV with the use of a number of new agents: palonos
作者: VALID    時(shí)間: 2025-3-26 05:23

作者: 狗窩    時(shí)間: 2025-3-26 10:08

作者: exhibit    時(shí)間: 2025-3-26 12:37

作者: conference    時(shí)間: 2025-3-26 17:18

作者: 不給啤    時(shí)間: 2025-3-27 00:51
First-Generation 5-HT3 Receptor Antagonists,rrent antiemetic therapy conceptually fulfills the true definition of “targeted therapy” as there is significant understanding of pathways involved in emesis as well as specific targeted antagonists to these pathways. This chapter will focus on the 5HT-3 pathway and the specific receptor antagonists
作者: 歡騰    時(shí)間: 2025-3-27 03:40
Palonosetron,-generation 5-HT. RAs were therapeutically equivalent with several large trials comparing these drugs to one another demonstrating similar efficacy [3, 4]. A plateau in 5-HT. RA activity had been reached. Efforts persisted to find potentially more active agents based on the understanding of the cent
作者: infringe    時(shí)間: 2025-3-27 05:25
Prevention of CINV in Patients Receiving High-Dose Multiple-Day Chemotherapy,, compounding the side effects of chemotherapy. Therefore, high-dose multiple-day chemotherapy with HSCT provides a unique challenge to achieving good antiemetic control and remains one of the neglected areas of antiemetic research. There are difficulties in developing evidenced-based recommendation
作者: 細(xì)節(jié)    時(shí)間: 2025-3-27 10:56

作者: flammable    時(shí)間: 2025-3-27 16:30

作者: VEST    時(shí)間: 2025-3-27 19:37

作者: Inordinate    時(shí)間: 2025-3-28 01:46

作者: 膽小懦夫    時(shí)間: 2025-3-28 02:30

作者: Anthrp    時(shí)間: 2025-3-28 07:24
Management of Chemotherapy-Induced Nausea and Vomiting978-3-319-27016-6
作者: AORTA    時(shí)間: 2025-3-28 11:08

作者: Herpetologist    時(shí)間: 2025-3-28 15:17

作者: 拋媚眼    時(shí)間: 2025-3-28 21:32

作者: LINE    時(shí)間: 2025-3-29 01:25
Roy Chen MD,Kathy Deng MD,Harry Raftopoulos MDy conservation is an established component of most self-management programmes for breathlessness within the context of long term disease and evidence suggests that such programmes improve confidence to manage breathlessness and reduce hospital admissions.
作者: 緩解    時(shí)間: 2025-3-29 03:09

作者: SEEK    時(shí)間: 2025-3-29 08:28
Thomas J. Guttuso Jr. MDheir causes is essential for better performance of any building and it is also a logical way of proceeding from the evidence to the cause of a defect, after which remedies can be prescribed. Appropriate solutions to mitigate the defect should be carried out to ensure the building are in a good perfo
作者: 行乞    時(shí)間: 2025-3-29 14:12
Luigi Celio MD can lead to building defects. The condition assessment finding was obtained through archived documentations and the result were analysed together with the interview results to validate the findings. The results were valid, and the conclusion of the research would be discussed in Chap. ..
作者: perjury    時(shí)間: 2025-3-29 18:12

作者: Arthropathy    時(shí)間: 2025-3-29 22:21

作者: 姑姑在炫耀    時(shí)間: 2025-3-29 23:58

作者: 繁榮地區(qū)    時(shí)間: 2025-3-30 05:45
Gabapentin for the Prevention of CINV,does increase brain GABA synthesis in rats and humans [3, 4]. Gabapentin’s mechanism of action for treating neuropathic pain, which is its main clinical use, is dependent upon its binding to the alpha-2/delta subunit of neuronal voltage-gated calcium channels [5] and likely involves the mitigation of neuronal calcium currents [6, 7].




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
丹寨县| 峨山| 黔江区| 长岛县| 化州市| 滦南县| 潞西市| 通州市| 洪湖市| 云浮市| 惠来县| 从化市| 浙江省| 运城市| 章丘市| 怀安县| 密云县| 曲靖市| 诸城市| 岑溪市| 石景山区| 马鞍山市| 台东县| 台山市| 六枝特区| 山东| 山东省| 唐海县| 秦皇岛市| 新郑市| 施甸县| 任丘市| 长兴县| 浦北县| 竹山县| 溧阳市| 巫溪县| 龙陵县| 青阳县| 辽阳市| 金华市|